{"paper_id":"78344d4f-9884-4636-bfa9-90471697fba6","body_text":"References\nFarland LV, Lorrain S, Missmer SA, Dartois L, Cervenka I, Savoye I, et al. Endometriosis and the risk of skin cancer: a prospective cohort study. Cancer Causes Control. 2017;28(10):1011–9.\nKim TH, Young SL, Sasaki T, Deaton JL, Schammel DP, Palomino WA, et al. Role of SIRT1 and progesterone resistance in normal and abnormal endometrium. J Clin Endocrinol Metab. 2022;107(3):788–800.\nSun T, Jiao L, Wang Y, Yu Y, Ming L. SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells. Cell Death Dis. 2018;9(2):136.\nWilking MJ, Singh C, Nihal M, Zhong W, Ahmad N. SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation. Arch Biochem Biophys. 2014;563:94–100.\nWang M, Wu Y, He Y, Liu J, Chen Y, Huang J, et al. SIRT1 upregulation promotes epithelial-mesenchymal transition by inducing senescence escape in endometriosis. Sci Rep. 2022;12(1):12302.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEthics declarations\nConflict of interest\nThe author declares no conflict of interest.\nAdditional information\nPublisher's Note\nSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.\nDr. Raffaella Mormile: Pediatrician and Neonatologist, Division of Pediatrics and Neonatology, Moscati Hospital Aversa, Italy.\nRights and permissions\nAbout this article\nCite this article\nMormile, R. Endometriosis and the Risk of Melanoma: A Shared Thread?. J Obstet Gynecol India 74, 562–563 (2024). https://doi.org/10.1007/s13224-024-02004-5\nReceived:\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s13224-024-02004-5","source_license":"CC0","license_restricted":false}